We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $861M
1-Year Est. Return 31.91%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+31.91%
3 Year Est. Return
+126.69%
5 Year Est. Return
+149.41%
10 Year Est. Return
+595.96%
AUM
$246M
AUM Growth
+$12.4M
Cap. Flow
+$4M
Cap. Flow %
1.62%
Top 10 Hldgs %
38.42%
Holding
118
New
7
Increased
68
Reduced
27
Closed
6
Avg Time Held
11.5 quarters
Top 10 Avg Time Held
10.6 quarters
Top 20 Avg Time Held
11.6 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.89%
2 Technology 18.3%
3 Financials 16.78%
4 Communication Services 11.51%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AMZN icon
51
Amazon
AMZN
$2.79T
$1.26M 0.51%
13,300
+300
+2% +$27.9K
2016 Q1
13 quarters
CVX icon
52
Chevron
CVX
$427B
$1.25M 0.51%
10,029
+2,535
+34% +$307K
2014 Q1
21 quarters
TIP icon
53
iShares TIPS Bond ETF
TIP
$14.3B
$1.19M 0.49%
10,338
-50
-0.5% -$5.69K
2016 Q4
10 quarters
XYL icon
54
Xylem
XYL
$23.9B
$1.16M 0.47%
13,820
+60
+0.4% +$4.78K
2016 Q1
13 quarters
TGT icon
55
Target
TGT
$69B
$1.14M 0.47%
13,211
+1,065
+9% +$86.1K
2018 Q1
5 quarters
SCHP icon
56
Schwab US TIPS ETF
SCHP
$16.2B
$1.13M 0.46%
40,012
+6
+0% +$166
2017 Q1
9 quarters
MU icon
57
Micron Technology
MU
$1.08T
$1.09M 0.44%
28,345
-220
-0.8% -$8.38K
2017 Q1
9 quarters
SCHG icon
58
Schwab US Large-Cap Growth ETF
SCHG
$65.3B
$1.08M 0.44%
103,840
+7,120
+7% +$72.4K
2017 Q2
8 quarters
KEY icon
59
KeyCorp
KEY
$21.2B
$1.07M 0.43%
60,270
-297
-0.5% -$5.02K
2014 Q1
21 quarters
AMRN icon
60
Amarin Corp
AMRN
$245M
$1.05M 0.43%
2,698
+201
+8% +$73.6K
2019 Q1
1 quarter
MCD icon
61
McDonald's
MCD
$167B
$1M 0.41%
4,827
-34
-0.7% -$6.74K
2014 Q1
21 quarters
MPT icon
62
Medical Properties Trust
MPT
$1.87B
$996K 0.4%
57,099
+4,505
+9% +$81.1K
2014 Q1
21 quarters
MMM icon
63
3M
MMM
$83.9B
$995K 0.4%
6,866
-41
-0.6% -$6.31K
2014 Q1
21 quarters
SCHR icon
64
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
$992K 0.4%
36,104
-196
-0.5% -$5.29K
2017 Q3
7 quarters
FLRN icon
65
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.06B
$981K 0.4%
31,927
-625
-2% -$19.2K
2018 Q2
4 quarters
HON icon
66
Honeywell
HON
$65.7B
$965K 0.39%
5,862
– –
2014 Q1
21 quarters
SRPT icon
67
Sarepta Therapeutics
SRPT
$1.74B
$938K 0.38%
+6,170
New +$750K
2019 Q2
0 quarters
CRM icon
68
Salesforce
CRM
$196B
$887K 0.36%
5,845
+85
+1% +$13.3K
2018 Q4
2 quarters
CVS icon
69
CVS Health
CVS
$112B
$787K 0.32%
14,445
-286
-2% -$15.4K
2018 Q2
4 quarters
VCIT icon
70
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.7B
$785K 0.32%
8,738
-44
-0.5% -$3.85K
2016 Q2
12 quarters
VZ icon
71
Verizon
VZ
$181B
$761K 0.31%
13,314
+341
+3% +$19.6K
2014 Q1
21 quarters
DIA icon
72
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$44.8B
$740K 0.3%
2,785
-25
-0.9% -$6.53K
2018 Q3
3 quarters
AGG icon
73
iShares Core US Aggregate Bond ETF
AGG
$137B
$697K 0.28%
6,261
+1,078
+21% +$118K
2014 Q1
21 quarters
SCHV icon
74
Schwab US Large-Cap Value ETF
SCHV
$15.4B
$697K 0.28%
37,233
+5,478
+17% +$101K
2018 Q2
4 quarters
XLK icon
75
State Street Technology Select Sector SPDR ETF
XLK
$129B
$660K 0.27%
16,912
+974
+6% +$37.1K
2017 Q3
7 quarters

Similar funds

Fagan Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Fagan Associates held 118 positions worth $246M, up 5.3% from $234M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Fagan Associates's Q2 2019 filing shows 7 new, 68 increased, 27 reduced and 6 closed positions. Its largest new stake was Advanced Micro Devices: 63,470 shares worth $1.93M. The largest sale was Regeneron Pharmaceuticals, an estimated $2.26M.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Fagan Associates's largest Q2 2019 buy was Advanced Micro Devices: 63,470 shares worth $1.93M.
  • Fagan Associates added most to Walt Disney in Q2 2019, an estimated $475K increase.
  • Fagan Associates's biggest Q2 2019 reduction was Intel, cutting an estimated $64.4K.
  • Fagan Associates fully exited Regeneron Pharmaceuticals in Q2 2019, selling an estimated $2.26M.
  • Fagan Associates's ten largest holdings make up 38% of its $246M portfolio in Q2 2019.
  • Fagan Associates opened 7 new positions and closed 6 in Q2 2019.
  • Fagan Associates's portfolio value rose 5.3% quarter-over-quarter to $246M.

Based on Fagan Associates's 13F filing for Q2 2019, filed 12 Jul 2019.